A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Summary: Prostate cancer is a tough disease, and a strong chemotherapy drug called docetaxel is often used to treat it. But there is a catch: this drug does not work for everyone, and it can cause harsh side effects. Until now, doctors haven't had a good way to know exactly who will get better with this drug and who will just suffer the side effects.

Recently, scientists created a smart computer program—an artificial intelligence (AI) tool—that looks at microscopic pictures of tumor biopsies. In a study of over 600 men, this AI accurately pointed out which patients would live longer by taking the drug, and which ones would not see any benefit. This is a huge breakthrough! It means doctors might soon use this AI to give the right treatment to the right person, saving many men from unnecessary and painful side effects.